FIGURE
Fig. S5
- ID
- ZDB-FIG-171228-8
- Publication
- Ma et al., 2015 - SKLB-677, an FLT3 and Wnt/?-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. S5
Zebrafish development experiments were used to examine the effect of the first-generation FLT3 inhibitors including CEP-701, MLN-518, sorafenib, and sunitinib on the Wnt/?-catenin signaling. CEP-701, MLN-518, sorafenib, or sunitinib was added to the fish water at 4hpf (more than 10 zebrafish embryos in each group). The representative images were taken after 24hpf. CEP-701 caused severe malformation and development delay. Scale bar, 200?m. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Sci. Rep.